BioAtla, Inc. (BCAB) Tops Q1 EPS by 13c

BioAtla, Inc. (NASDAQ: BCAB) reported Q1 EPS of ($0.26), $0.13 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
• Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell